Form 4: D. Keith Grossman Acquires 25,000 Shares of Outset Medical, Inc. (OM) via Restricted Stock Units

Director D. Keith Grossman acquired 25,000 shares of Outset Medical, Inc. through restricted stock units (RSUs) on May 29, 2024.

Summary

• On May 29, 2024, D. Keith Grossman, a director of Outset Medical, Inc., acquired 25,000 shares of common stock through the grant of restricted stock units (RSUs).
• The RSUs were acquired at a price of $0.00 per share.
• Following the transaction, Grossman directly owns 42,849 shares of Outset Medical, Inc.
• Grossman also indirectly owns 5,186 shares through the Grossman Family Trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard transaction. The director's increased stake could be seen as mildly positive, but it's a routine event.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders.

Industry Context

This filing is a routine disclosure related to insider transactions and provides insight into the holdings of company directors. It's common for directors to receive stock-based compensation as part of their overall remuneration.

Comparison to Industry Standards

• Stock grants to directors are a common practice in publicly traded companies, used to align the interests of management with those of shareholders.
• The size of the grant is typical for director-level compensation, but the specific value depends on the company's compensation policies and performance.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.

Key Dates